Introduction
'Mitotic catastrophe' has been first described in Schizosaccharomyces pombe as a temperature-sensitive lethal phenotype, linked to gross abnormalities of chromosome segregation, that was observed in some mutant strains (Molz et al., 1989; Ayscough et al., 1992) . Accordingly, some authors view 'mitotic catastrophe' of mammalian cells as the failure to undergo complete mitosis (which would be more accurately called 'mitotic failure') after DNA damage (coupled to defective checkpoints), a situation that would lead to tetraploidy (after a single cell cycle) (Andreassen et al., 2001a; Margottin-Goguet et al., 2003) or endopolyploidy (after several cell cycles) with extensive DNA damage and repair, perhaps followed by the selection of apoptosis-resistance cells that will ultimately survive after endoreduplication (Ivanov et al., 2003) .
During recent years, the expression of 'mitotic catastrophe' has been widely used to describe a form of death affecting mammalian cells. Unfortunately enough, there is no broadly accepted definition of the term 'mitotic catastrophe'. Igor Roninson attempted to define mitotic catastrophe in morphological terms, namely, as a type of cell death resulting from abnormal mitosis, which usually ends in the formation of large cells with multiple micronuclei and decondensed chromatin (Swanson et al., 1995; Ianzini and Mackey, 1997; Roninson et al., 2001) . However, reports describing 'mitotic catastrophe' frequently show cells with some phenotypic characteristic of apoptosis (such as hypercondensed chromatin aggregates) (Heald et al., 1993) , which previously often was interpreted as 'premature chromatin condensation' (Sperling and Ra, 1974; Chakrabarti and Chakrabarti, 1987) . Thus, there is no consensus on the distinctive morphological appearance of mitotic catastrophe as far as the extent of chromatin condensation (which is the morphological hallmark of apoptosis) (Kerr et al., 1972; Ferri and Kroemer, 2001a) is concerned.
It has been argued that mitotic catastrophe would be fundamentally different from apoptosis (Roninson et al., 2001) because, in some paradigms, manipulations that prevent apoptosis (such as overexpression of Bcl-2 in etoposide-treated HeLa cells or MDR1 overexpression in irradiated tumor cells) can actually enhance the frequency of catastrophic mitoses (Lock and Stribinskiene, 1996; Ruth and Roninson, 2000) . It has also been argued that the assessment of micronucleation (which would indicate mitotic catastrophe) can yield a more accurate picture of cell death induction in vivo than the quantitation of apoptosis (Driessens et al., 2003) .
Moreover, the fact that caspase inhibitors such as Z-VAD.fmk can fail to prevent the appearance of dying giant multinucleated cells (induced, for instance, by treatment with spindle poisons) has been used to conclude that mitotic catastrophe would be unrelated to apoptosis (Nabha et al., 2002) , assuming that apoptosis must be mediated by caspases. However, it is now well established that apoptosis may occur in a caspase-independent manner (Susin et al., 1999 (Susin et al., , 2000 Joza et al., 2001) , meaning that failure to prevent cell death by caspase inhibitors cannot be used as an argument to define this type of cell death as nonapoptotic.
An alternative definition of mitotic catastrophe may be considered as near-to-tautological. Mitotic catastrophe would be a type of cell death occurring during mitosis, as a result of DNA damage or deranged spindle formation coupled to the debilitation of different checkpoint mechanisms that would normally arrest progression into mitosis and hence suppress catastrophic events until repair has been achieved. The 'DNA structure checkpoint' arrests cells at the G2/M transition in response to unreplicated DNA or DNA damage, and the 'spindle assembly checkpoint' prevents anaphase until all chromosomes have obtained bipolar attachment. The combination of checkpoint deficiencies and specific types of damage would lead to mitotic catastrophe. Thus, the pharmacological inhibition or genetic suppression of several G2 checkpoint genes such as ATM, ATR, Chk1, Chk2, polo-like kinase (Plk)1, Plk2, Plk3, Pin1, Mlh1 and 14-3-3-s can promote DNA-damage-induced mitotic catastrophe (Bunz et al., 1998; Chan et al., 1999; Roninson et al., 2001; Chen et al., 2003) . Damage leading to mitotic catastrophe can be induced, in particular, by microtubule-hyperpolymerizing agents (taxanes, elutherobins, epothilones, laulimalide, sarcodictyins, docodermolide) and by microtubule-depolymerizing agents (such as the Vinca alkaloids, cryptophyscins, halichondrins, estramustine and colchicine) as well as by DNA damage (Roninson et al., 2001) . Since cancer cells are frequently deficient in cell-cycle checkpoints, they may be particularly susceptible to the induction of mitotic catastrophe by such drugs. Mitotic catastrophe can also be induced by fusion of mitotic cells with interphase cells in S or G2, as a result of premature induction of mitosis before the completion of S or G2 (Castedo et al., 2004a) . Overduplication of centrosomes (which leads to multipolar mitosis) (Sato et al., 2000) or failure of centrosomes to undergo duplication (with consequent failure of chromosomes to segregate) (Cogswell et al., 2000) may also lead to mitotic catastrophe.
The present review is aimed to examine the question which are the major processes dictating mitotic catastrophe, in molecular and genetic terms. Special attention will be paid to the relationship between mitotic catastrophe and apoptosis. Based on the information presently available in the literature, we will thus propose a tentative molecular definition of mitotic catastrophe.
Molecules and processes involved in mitotic catastrophe
Cdk1/cyclin B1 complex: essential for mitosis and mitotic catastrophe
The cyclin-dependent kinase 1 (Cdk1), formerly called Cdc2 (or p34 Cdc2 ), interacts with its obligate allosteric activator, cyclin B1 to form an active heterodimer, the 'mitosis-promoting factor'. Progression from G2 to M phase is driven by the activation of the Cdk1/cyclin B1 complex, whose activity must be sustained from prophase to metaphase. Subsequent entry into the anaphase critically relies on the sudden destruction of the Cdk1/cyclin B1 activity by the anaphase-promoting complex (APC) (Nigg, 2001; Smits and Medema, 2001) (Figure 1) . Accordingly, the activity of Cdk1 is regulated in a complex spatiotemporal pattern at several levels, namely, (i) the transcription of cyclin B1 and (to a lower extent) that of Cdk1, (ii) regulatory Cdk1 (de)phosphorylations by multiple kinases and phosphatases, (iii) endogenous Cdk1 inhibitors, (iv) the subcellular distribution of cylin B1, and (v) the regulated degradation of cyclin B1.
The transcription of Cdk1 is modulated in conditions of genotoxic stress. For instance, p53 negatively regulates the transcription of Cdk1 (Yun et al., 1999) and cyclin B1 (Taylor et al., 1999) , while enhancing the transcription of three Cdk1 inhibitors (Gadd45, p21 and 14-3-3s) (Taylor and Stark, 2001 Cip1/Waf1 directly inhibits Cdk1 activity. Cyclin B1 translocates from the cytosol to the nucleus, early during mitosis. The equilibrium between nuclear import and export of cyclin B1 (as well as that of Cdc25C, required for the activation of Cdk1) is influenced by its phosphorylation status (Nigg, 2001; Smits and Medema, 2001) , as well as by cytoplasmicbinding proteins such as 14-3-3s (Chan et al., 1999) . At the end of the metaphase, the APC (also called 'cyclosome') must destroy cyclin B1 to allow mitosis to proceed (Peters, 2002) . The APC has a critical E3 ubiquitin ligase activity and directs the assembly of multiubiquitin chains on specific substrates and their subsequent degradation by the 26 S proteasome (Yu, 2002) . The APC selects substrates by using the Cdc20 or Cdh1 adaptor proteins to recognize a specific sequence (destruction box) in cyclin B1.
The Cdk1/cyclin B1 heterodimer induces mitosis by phosphorylating and activating enzymes regulating chromatin condensation, nuclear membrane breakdown, mitosis-specific microtubule reorganization and the actin cytoskeleton allowing for mitotic rounding up of the cell (Nigg, 2001) . The perfect regulation of the spatiotemporal pattern of Cdk1/cyclin B1 activity is pivotal for the normal cell cycle and is subject to multiple control steps. Thus, the so-called 'DNA structure checkpoints' (which are activated by incomplete DNA replication or by DNA damage such as strand breaks) will stimulate Wee1/Myt1 as well as the so-called checkpoint kinases (Chk1, Chk2) to prevent Cdk1 activation and entry into mitosis. Similarly, the APC can be inhibited during the 'spindle assembly checkpoint', thus preventing the degradation of cyclin B1 and securin (and that of many other substrates) and nuclear division (Nigg, 2001; Smits and Medema, 2001; Melo and Toczyski, 2002) .
Aberrant mitotic entry, before the completion of DNA replication, can result in mitotic catastrophe. Obviously, this requires the activation of Cdk1, and it is currently assumed that premature entry of active Cdk1/ cyclin B1 complex into the nucleus suffices to cause premature chromatin condensation and apoptosis (Heald et al., 1993; Fotedar et al., 1995; Jin et al., 1998; Porter et al., 2003) . Increased nuclear cyclin B1 has been found in numerous examples of mitotic catastrophe induced by pharmacological or genetic manipulations, for instance, in human colorectal adenocarcinoma cell lines treated with fluorouracil (Yoshikawa et al., 2001), 14-3-3s À/À colon cancer cells treated with doxorubicin (Chan et al., 1999) , as well as in heterokarya induced by cell fusion (Castedo et al., 2001 (Castedo et al., , 2002b . The inhibition of Cdk1 by the expression of a dominant-negative (DN) mutant or chemical inhibitors such as roscovitine or olomoucine prevents the apoptosis of heterokarya (Castedo et al., 2001) , including the mitotic catastrophe promoted by Chk2 inhibition (Castedo et al., 2004b) . Prolonged inhibition of the APC (which results into prolonged Cdk1 activation) can also result in mitotic catastrophe associated with centrosome overduplication. Thus, a recent study indicates that overexpression of Emi1, a protein that inhibits the APC in S and G2, or failure to degrade Emi1 (via action of the SCFBTCRP/Slimb ubiquitin ligase) leads to the stabilization of APC substrates and mitotic deficiencies (Margottin-Goguet et al., 2003) .
An increase in Cdk1 activity has also been found in numerous apoptotic conditions, and inhibition of the Cdk1/cyclin B1 complex by a DN Cdk1 mutant, antisense constructs or chemical inhibitors have suggested that this increase in activity may be indeed ) has been removed by active Cdc25C phosphatase, that Cdk1 associates with cyclin B and that the complex translocates to the nucleus. In the nucleus, the active Cdk1/cyclin B complex then phosphorylates mitotic substrate proteins. During the anaphase, the APC becomes activated and destroys Cdk1, a step that is a conditio sine qua non for entry into the anaphase. The DNA structure checkpoint activates checkpoint kinases (such as Chk1 and Chk2), which phosphorylate Cdc25C on Ser 216 , thereby causing its inactivation (and failure to activate Cdk1). The activation of the spindle checkpoint delays maturation of the APC (and thus prevents cyclin B degradation) important for cell killing (Fotedar et al., 1995; Castedo et al., 2002a) . In HL60 myelomonocytic leukemia cells, taxol-induced Cdk1 activation is not affected by Bcl-2 nor is it inhibited by the pancaspase inhibitor Z-VAD.fmk, although Bcl-2 (but not Z-VAD.fmk) does prevent the mitochondrial release of cytochrome c (Cyt. c) (Ibrado et al., 1998) . This places Cdk1 upstream of the Bcl-2-regulated mitochondrial changes that define apoptosis (Kroemer and Reed, 2000; Ferri and Kroemer, 2001b) . Cdk1 can induce mitochondrial membrane permeabilization (MMP) by phosphorylating the proapoptotic Bcl-2 protein family member Bad on Ser 128 , thereby causing a loss of interaction between Bad and cytosolic 14-3-3 proteins (Konishi et al., 2002) . As a result, Bad can translocate to mitochondria, where it antagonizes Bcl-2-like proteins and/or activates Bax-like proteins (Debatin et al., 2002) and causes cell death (Konishi et al., 2002; Letai et al., 2002) . Alternatively, the prolonged activation of Cdk1 may increase, via indirect mechanisms, the activity of p53, which causes the transcription of proapoptotic proteins of the Bcl-2 family such as Bax and Puma, thereby initiating mitochondrial apoptosis (Castedo et al., 2001 (Castedo et al., , 2004b Perfettini et al., 2004) . However, the detailed mechanisms through which Cdk1 can facilitate apoptosis induction are far from clear and it is well possible that Cdk1 facilitates apoptosis through more indirect mechanisms, for instance by initiating mitosis, thereby laying the grounds for the forthcoming mitotic catastrophe.
DNA damage sensors and Chk2: avoiding mitotic catastrophe
An intact DNA structure checkpoint is important for avoiding mitotic catastrophe. DNA damage such as double-strand breaks or pyrimidine dimers is perceived by sensors (which include RAD1, RAD9, RAD17 and HUS7) and then relayed to kinases such as the related phosphatidylinositol-3-OH-kinase-like kinase, ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3 related (ATR) that ultimately activate, via phosphorylation, yet another kinase, such as the Chk2, which halts the cell cycle. This cascade is conserved throughout evolution. Rad53p, the yeast (S. cerevisiae) Chk2 homologue, is activated by Mec1p, the yeast ATM/ATR homologue, during the S phase checkpoint that avoids entry into mitosis before DNA replication is completed (Allen et al., 1994; Weinert et al., 1994; Clarke et al., 1999) . In yeast, Mec1p and Rad53 repress the accumulation of the APC specificity factor Cdc20p, a protein whose overexpression during the S phase suffices to cause catastrophic mitosis (Clarke et al., 2003) .
In Drosophila melanogaster, Chk2 is also required for the activation of a DNA damage response. In syncytial Drosophila embryos, damaged or incompletely replicated DNA triggers centrosome disruption in mitosis, thus resulting in defective spindle assembly and anaphase chromosome segregation. The damaged nuclei accumulate in the cortex of the syncytial embryo and are not incorporated into the cells that form the proper embryo. Disruption of the Drosophila Chk2 homologue (DmChk2) blocks this mitotic response to DNA lesions and also prevents the loss of defective nuclei from the cortex (Takada et al., 2003) . This phenotype, induced by knock out of the DmChk2 gene, is partially suppressed by reducing the gene dosage of the Plk polo, the only member of the Plk gene family in the fly (Xu and Du, 2003) .
In response to DNA damage, Chk2 localizes to centrosome and spindle microtubules in Drosophilia (Takada et al., 2003) , while it colocalizes and interacts with Plk1, in centrosomes and the midbody in human cells (Tsvetkov et al., 2003) , suggesting that Chk2 couples centrosome function and spindle assembly to genomic integrity via Plk1. In mammals, Chk2 probably functions as an effector through phosphorylation of additional key substrates such as the transcription factor p53 (Chehab et al., 2000; Sheih et al., 2000) , the cellcycle-regulating phosphatases Cdc25A (Falck et al., 2000) and Cdc25C (Peng et al., 1997) , Mdm2 (Sheih et al., 2000) , BRCA1 (Lee et al., 2000) and PML (Yang et al., 2002) , and perhaps Abl1, Bub1R, Bub1, Bub3, Psk-H1, Smc3, Plk1, Cdc25B, Dcamkl1, Mre11, Pms1 and Xrcc9 (Seo et al., 2003) . In addition, Chk2 phosphorylates the transcription factor E2F1 on serine 364, thereby activating the transcriptional upregulation of the proapoptotic proteins Apaf-1 and p73 (Stevens et al., 2003) . In accordance, with these pleiotropic effects, Chk2 can have an apoptosis-sensitizing effect and can arrest the cell cycle at different stages (Figure 2) .
Recent data imply Chk2 as a negative regulator of mitotic catastrophe in human cells. The inhibition of Chk2 prevents the activation of a DNA structure checkpoint, which normally arrests the cell cycle of nonsynchronous HeLa heterokarya at the G2/M bor- Figure 2 Contribution of Chk2 to the regulation of apoptosis. DNA damage occurring during the G1, S or G2 'phases can lead to the activation of Chk2, which then acts in a pleiotropic manner to phosphorylate the transcription factor E2F1 (which facilitates the induction of at least two proapoptotic proteins, Apaf-1 and p73). In addition, Chk2 inhibits Plk1 (which function as an endogenous repressor of mitotic catastrophe) activates two proapoptotic proteins, namely, PML and p53 (by direct phosphorylation or indirectly by inhibiting the p53 antagonist MDM2) and provokes a cell-cycle arrest via the phosphatases CDC25A and CDC25C der. In a system of continuous syncytium formation, induced by the coculture of two different HeLa cell lines expressing the HIV-1 envelope (Env) or CD4, respectively (Ferri et al., 2000a, b) , polyploid cells normally arrest at the early prophase of the cell cycle, after dismantling of the nuclear envelope but before spindle formation, correlating with a sudden loss of cyclin B1 and then undergo p53-dependent apoptosis after a latency phase (Castedo et al., 2001 (Castedo et al., , 2004b . Cell fusion is also accompanied by the activating phosphorylation of Chk2 on Thr68, which colocalizes with BRCA nuclear bodies (Castedo et al., 2004b) and phosphorylated histone H2AX (Figure 3 ). The suppression of Chk2 by the overexpression of a kinase-dead DN Chk2 mutant or pharmacological inhibition with debromohymenialdisine over-rides this arrest, maintains high cyclin B1 levels and Cdk1 activities, and causes the cells to proceed until metaphase. Thus Chk2-inhibited heterokarya manifest metaphases with multiple spindles. The cells then exhibit signs of apoptosis including Cyt. c release, caspase-3 activation and TUNEL-detectable DNA fragmentation (Castedo et al., 2004a, b) . The inhibition of Chk2 can also abolish the cell-cycle arrest normally induced by doxorubicin treatment in HCT116 cells, thereby facilitating apoptosis induction (Castedo et al., 2004a, b) . In this cell line, the ablation of the 14-3-3-s locus also abolishes the G2 arrest and causes mitotic catastrophe linked to the premature entry of cyclin B/ Cdk1 into the nucleus (Chan et al., 1999) . Of note, 14-3-3-s À/À cells manifest a reduced activation of Chk2. Moreover, the inhibition of Chk2 abolishes the phenotypic difference between 14-3-3-s-sufficient and -deficient cells (Castedo et al., 2004b) , suggesting that the phenotype of 14-3-3-s À/À cells is actually due to an inhibition of Chk2 activation.
The inhibition of Chk2 (and Chk1) by 7-hydroxystaurosporine (UCN-01) also abrogates the g-radiationinduced G2-M checkpoint and thus enhances g-radiation-induced apoptosis . Clinical trials involving a combination of UCN-01 and DNA-damaging agents are underway and have yielded encouraging results for patients with melanoma and refractory anaplastic large-cell lymphoma (Senderowicz, 2003) . However, it is not clear which of the effects of UCN-01 may actually be attributed to the inhibition of Chk2 (rather than that of other kinases), and whether the inhibition of Chk2 will not ultimately increase or accelerate genomic instability, thereby favoring the development of therapy-resistant tumor cells or even secondary cancers.
Mutations in human Chk2 increase genomic instability and are linked to cancer. Thus, heterozygous mutations in Chk2 (e.g. the protein-truncating mutation, 1100delC in exon 10 or the R145W mutation that compromises the stability of the Chk2 protein) are found in a subset of patients with the multicancer LiFraumeni syndrome (Bell et al., 1999) . The 1000delC mutation has also been found in a fraction of patients with breast cancer (Meijers-Heijboe et al., 2002; Vahteristo et al., 2002) . Patients with bilateral mammary carcinomas exhibit a sixfold increase in the incidence of the Chk2 1000delC mutation as compared to patients with unilateral tumors (Vahteristo et al., 2002) . Other germline Chk2 mutations affecting the catalytic region or regulatory domains (Wu et al., 2001b) have also been linked to breast cancer (Meijers-Heijboe et al., 2002) and other malignancies including osteosarcoma (Miller et al., 2002) . A somatic mutation of Chk2 has been detected in myelodysplastic syndrome (Hofmann et al., 2001) . This indicates that the pharmacological suppression of Chk2 might indeed have adverse tumor-promoting effects.
In summary, it appears that the DNA structure checkpoints and Chk2 negatively regulate mitotic catastrophe, meaning that the inactivation of Chk2 (and of its activating partners) can sensitize to this type of cell death. Although attractive, the possibility to inhibit Chk2 (and similar enzymes) for chemosensitization has to be validated by extensive biological and clinical tests.
Survivin at the interface between mitotic checkpoint control and apoptosis suppression?
In the context of the specific topic of this review, survivin appears to be a particularly fascinating protein, for at least three reasons. First, survivin is frequently overexpressed in cancers, correlating with abbreviated survival, unfavorable prognosis, resistance to therapy and accelerated rates of recurrences (Altieri, 2003) . Second, survivin is a member of the inhibitor of apoptosis protein gene family and has been postulated to suppress caspase activation (Li et al., 1998) . Third, survivin demonstrates a particular cell-cycle-dependent pattern of subcellular distribution, is a substrate of Cdk1, and actually contributes to the spindle checkpoint (Lens et al., 2003) .
The mitotic checkpoint pathway is regulated by a group of evolutionarily conserved genes that include mitotic arrest deficient MAD1, MAD2, MAD3 (or BUBR1), BUB1, BUB3 and MPS1 (Burke, 2000) . These proteins preferentially bind to the kinetochores of unattached chromosomes where they are thought to generate the signal that suppresses anaphase onset (Burke, 2000; Shah and Cleveland, 2000) . Treatment of cells with chemicals that perturb microtubule Mitotic catastrophe M Castedo et al dynamics will lead to sustained activation of the spindle checkpoint and often triggers apoptosis. In HeLa cells treated with nocodazole, activation of p38 has been linked to apoptosis induction. p38 activation would be required for the translocation of Bax to mitochondria (Deacon et al., 2003) . In addition, overexpression of the MAD checkpoint proteins has also been reported to sustain the activity of the spindle checkpoint and causes a mitotic arrest that is frequently followed by apoptosis (Geley et al., 2001) . Moreover, depletion of CMT2 (an MAD2-binding protein) (Habu et al., 2002) or hNuf2 (DeLuca et al., 2002) leads to a blockade in the prometaphase/anaphase transition with consequent death.
At the beginning of mitosis, survivin associates with microtubules of the mitotic spindle, forming a complex with INCENP (inner centromere-binding protein) and the Aurora B kinase (O'Connor et al., 2002; Wall et al., 2003) . The knock out of survivin and that of its binding partner INCENP has a similar phenotype, with disrupted microtubule formation, polyploidy and massive apoptosis, as well as embryonic cell death on day 4.5 (Cutts et al., 1999; Uren et al., 2000) . Recent studies provide evidence that survivin is required for a sustained mitotic arrest in response to the lack of tension at the kinetochore (Carvalho et al., 2003; Lens et al., 2003) . Indeed, when survivin is depleted by small interfering RNA (siRNA), cells manifest a prometaphase delay (B3-4 h) and then exit mitosis without attaining chromosome alignment while reforming a single tetraploid nucleus. In survivin-depleted cells, BubR1 is prematurely displaced from kinetochores, and the prometaphase delay induced by survivin depletion is completely abrogated when Mad2 and BubR1 are codepleted (Lens et al., 2003) . Survivin depletion also causes a failure of taxol-induced mitotic arrest (Carvalho et al., 2003; Lens et al., 2003) . Clearly, in these latter studies depletion of survivin led to a prominent defect in mitosis, without any apparent direct induction of apoptosis. This would suggest that a role for survivin as a protection from apoptosis is rather secondary to its role during mitosis.
Transgenic expression of survivin has been reported to prevent apoptosis induction by mitochondriondependent cell death inducers such as UVB light (Grossman et al., 2001) . Survivin antisense oligonucleotides administered to a human neuroblastoma (MSN) cell line cause caspase-independent cell death (with multiple large macronuclei with no apoptotic bodies) accompanied by the mitochondrionuclear translocation of apoptosis-inducing factor (AIF) (Shankar et al., 2001) , an important caspase-independent death effector (Cande et al., 2002; Penninger and Kroemer, 2003) . In contrast, the same survivin antisense oligonucleotide can induce caspase activation and full-blown chromatin condensation in the oligodendroglioma (TC620) line (Shankar et al., 2001) . In HL60 cells, survivin antisense induces the release of mitochondrial apoptosis factors including Cyt. c, AIF and Smac/DIABLO (Carter et al., 2003) . Altogether, these data suggest that survivin functions as an endogenous repressor of the mitochondrial pathway of apoptosis. How this inhibitory effect is achieved remains obscure. Direct regulation of caspase activity by survivin has been proposed , but later disputed (Verdecia et al., 2000) . In addition, it has been reported that survivin interacts with Smac/ DIABLO (Song et al., 2003) and it has been suggested that this interaction would prevent the activation of downstream caspases, at the postmitochondrial level. However, this would not explain how survivin can regulate MMP and caspase-independent cell death. Thus, it is presently unclear if and how the mitotic roles of survivin relate to its proposed role as an inhibitor of apoptosis, but it remains tempting to speculate that survivin play an important role in the coupling of abnormal mitotic progression to the onset of mitotic catastrophe.
p53 and the polyploidy checkpoint
Upon spindle damage, cells become transiently arrested at the metaphase-anaphase transition point and then escape from the block (a process termed 'mitotic slippage') and exit mitosis without proper segregation of sister chromatids and cytokinesis. Spindle-damaged cells then definitively arrest at a tetraploid G1 state because they activate a checkpoint. This arrest is mediated through p53, while the transient arrest at the metaphase-anaphase transition and mitotic slippage are probably not influenced by p53 (Lanni and Jacks, 1998), although some reports have suggested that the absence of p53 might increase mitotic slipperage, thus increasing the frequency of tetraploid cells (Tsuiki et al., 2001 ). There is a broad consensus that p53-deficient cells that are in the tetraploid G1 state are not prevented from reentering the cell cycle to reduplicate their DNA unchecked, leading to polyploidy and subsequent chromosomal instability. In the presence of p53, tetraploidy (or polyploidy in general) causes the activation of p21 and an irreversible arrest in the cell cycle (or cell death), thereby preventing the propagation of errors of late mitosis and the generation of aneuploidy (Lanni and Jacks, 1998; Andreassen et al., 2001b) . The absence of p21 also relaxes the polyploidy checkpoint and thus cause hematopoietic MO7e cells to manifest centriole overduplication with polyploidy and multilobular nuclei in response to nocodazole (Mantel et al., 1999) , suggesting that p21 is one of the major p53 target genes in this context. However, it has been reported that a p53 mutant that is transcriptionally silent (p53-135Val) can replace wild-type p53 in the inhibition of polyploidy (Notterman et al., 1998) , suggesting that the functional requirements for p53 in diploid cells are different from those mediating the arrest of tetraploid cells. Importantly, the overexpression of Bcl-2 allows polyploid p53-deficient cells, generated by nocodazole treatment, to survive (Minn et al., 1996) . Thus, p53 abrogation and apoptosis inhibition can cooperate to induce rapid and progressive polyploidization following mitotic spindle damage.
The absence of functional p53 is permissive for the generation/survival of polyploid cells in a number of in vitro systems; HeLa cells proliferating in vitro without any treatment other than antisense p53 (Iotsova and Stehelin, 1995) , human leukemia cell lines treated with nocodazole ( (Verdoodt et al., 1999) , U87MG glioma cells exposed to 1,3-bis(2choroethyl)-1-nitrosourea (Wu et al., 2001a) , Msh2-deficient fibroblasts treated with cisplatin (Strathdee et al., 2001) , the 32D murine myeloid cell line manipulated to overexpress c-myc (Yin et al., 1999) , murine T cells subjected to mitotic arrest (Baek et al., 2003) , or mouse embryonic fibroblasts treated with IC261, an inhibitor of casein kinase-1d and -e (Behrend et al., 2000) , or fused with polyethylene glycol (Castedo et al., 2001) , just to give a few examples. The overexpression of Aurora-A, Aurora-B and Plk causes cell division defects with consequent multinucleation (mostly tetraploidization) and an increase in centrosome number. This phenotype is exacerbated in p53-negative cells, suggesting that the inability to detect hyperploidy favors the emergence of numerical chromosome aberrations (Meraldi et al., 2002) . Another cancer-relevant example is provided by endopolyploid cells generated by the expression of Kcyclin (the Kaposi's sarcoma-associated herpesvirus cyclin D homologue). Such cells manifest multinucleation, polyploidy, centrosome amplification and consequent aneuploidy, provided that p53 is inactivated (Verschuren et al., 2002) . When p53 is present, it is activated at the stage of polyploidy and causes cell death (Verschuren et al., 2002) . It is possible that the downregulation of p53 by overexpressed MDM2 is also permissive for the physiological polyploidization of megakaryocytes (Datta and Long, 2002) . Indeed, megakaryocyte differentiation is tightly linked to endoreduplication cycles with aborted (metaphasearrested) mitoses of a transcriptionally active genome (Raslova et al., 2003) , and this correlates with a decrease in p53 protein levels.
That p53 can actually suppress polyploidy is also suggested by a series of observations in vivo, in the mouse. Thus, the inactivation of p53 by SV40 transgenes can lead to tetraploidy in the mouse pancreas (Ramel et al., 1995) as well as to cytological abnormalities (anisokaryosis and anisocytosis) in the mouse liver (Gillet et al., 2000) . This latter effect is prevented by the overexpression of transgenic wild-type p53 (Gillet et al., 2000) . p53 knockout mice manifest the accumulation of multinuclear cells in the prostate (Colombel et al., 1995) and in the testis (Rotter et al., 1993) . The absence of p53 allows for the persistence of multinuclear cells upon wound healing in vivo (Oberringer et al., 1999) . The link between p53 abrogation and aneuploidy has also been established in a series of human cancers. Thus, 17p (p53) allelic losses occur in diploid cells of patients with Barrett's esophagus, before aneuploidy becomes manifest (Blount et al., 1994) . In head and neck cancer, a close spatial correlation between p53 mutation and increased chromosome polysomy has been observed (Shin et al., 2001) . Generally, it appears that p53 mutation predisposes to chromosomal instability, perhaps due to deficient activation of the polyploidy checkpoint.
Importantly, the loss of p53 can sensitize cells to microtubule poisons such as paclitaxel (Taxol) (Hawkins et al., 1996; Wahl et al., 1996; Vikhanskaya et al., 1998) due to its capacity of inactivating the polyploidy checkpoint. After treatment with spindle inhibitors, cells possessing an intact p53 system undergo a p21-mediated G1 arrest after adaptation and thus are resistant to antimicrotubule agents. Cells deficient for p53 fail to undergo such a G1 arrest (since they fail to upregulate p21) and endoreduplicate their DNA, leading to massive apoptosis, mainly during the S phase (Minn et al., 1996; Di Leonardo et al., 1997; Lanni and Jacks, 1998) . Recently, it has been found that there is an additional mechanism through which the absence of p53 can sensitize to paclitaxel-induced cell death, namely via Plk2 (Burns et al., 2003) , as discussed in the following section.
Plks in mitotic catastrophe
One of the p53-induced genes is Plk2 (also called seruminducible kinase, Snk). Knock down of Plk2 using siRNA sensitizes cells to apoptosis induction upon treatment with paclitaxel or nocodazole. This cell death occurs during mitosis, in cells containing 4N of chromosomes and high cyclin B1 levels. It is accompanied by caspase-3 activation (Burns et al., 2003) , indicating that it involves the activation of the apoptotic machinery. It thus has been suggested that Plk2 would be an endogenous inhibitor of mitotic catastrophe whose expression is under the control of p53.
Plk2 is just one member of a larger family of kinases that also comprises Plk1 and Plk3. The inhibition of Plk1 with siRNA results in spindle defects, arrest at prometaphase and cytokinesis defects resulting into apoptosis (Spankuch-Schmitt et al., 2002; Liu and Erikson, 2003) . Similar effects were found when tumor cells were treated with a peptide corresponding to the amino acids 410-429 of Plk1 fused to an Antennapedia peptide that renders it plasma membrane permeable. Upon the addition of this peptide (which is likely to act as an inhibitor of endogenous Plk1), MCF-7 or HeLa S3 cells manifest mitotic alterations with multipolar spindles and apoptosis (Yuan et al., 2002) . The overexpression of a DN Plk1 has also been reported to induce a G2/M arrest, mitotic alterations (but with frequent monoastral mitoses) and apoptosis (Cogswell et al., 2000) . An antisense approach designed to reduce the expression of Plk1 has therapeutic effects on human tumors xenotransplanted into immunodeficient mice, in particular, when combined with antisense Bcl-2 (Elez et al., 2003) , suggesting that it does involve apoptosis.
The overexpression of a kinase-defective mutant of Plk3 (Plk3K52R, which may well behave like a DN Plk3) also arrests mammalian cells in the G2/M phase and kills them, accompanied by the accumulation of cyclin B1 and the caspase-cleaved PARP p85 fragment (Wang et al., 2002) . These death-inducing effects are found even in the absence of stress (such as microtubule poisons), indicating that Plk1 and Plk3 (whose down-regulation/inhibition kills in the absence of stress) and Plk2 (whose downregulation only kills in the presence of antimicrotubule agents) are not functionally equivalent. However, it remains an open conundrum whether aberrant mitosis (facilitated by the depletion of Plks) simply induced apoptosis through identical mechanisms, without any direct impact of these kinases on the apoptotic machinery.
Mitotic catastrophe and the apoptotic machinery
As discussed above, mitotic catastrophe can be considered as a type of cell death occurring during mitosis or resulting from mitotic failure. At least two subtypes of mitotic catastrophe can be distinguished. First, mitotic catastrophe can kill the cell during or close to the metaphase, in a p53-independent manner, as this occurs in Chk2-inhibited syncytia or Plk2-depleted cells. Second, mitotic catastrophe can occur after failed mitosis, during the activation of the polyploidy checkpoint, in a partially p53-dependent manner.
Mitotic catastrophe is accompanied by chromatin condensation (Figure 4a ), mitochondrial release of proapoptotic proteins (in particular Cyt. c and AIF) (Figure 4b and c), caspase activation ( Figure 4d ) and DNA degradation (Figure 4c ). This implies that mitotic catastrophe is accompanied by the key molecular events defining apoptosis, namely, capase activation and MMP (Green and Kroemer, 1998; Zamzami and Kroemer, 2003) . The inhibition of caspases can prevent or at least retard the metaphase-associated cell death (not shown). Importantly, in several paradigms, transfection with MMP inhibitors (Zamzami et al., 1998) such as Bcl-2, Bcl-XL or the Cytomegalovirus vMIA gene (also called UL37), or knock out of Bax can prevent mitotic catastrophe. This has been shown for the two subtypes of mitotic catastrophe mentioned above (Minn et al., 1996; Ferri et al., 2000a; Castedo et al., 2001 Castedo et al., , 2004a Roumier et al., 2003; Perfettini et al., 2004) , again underlining the importance of the apoptotic machinery (and in particular of the intrinsic, mitochondrial pathway) for the execution of mitotic catastrophe. In accord with this notion, it has also been shown that inhibition of Bcl-2 expression by antisense oligonucleotides can actually facilitate and amplify mitotic catastrophe (Elez et al., 2003) .
If mitotic catastrophe is characterized by MMP and caspase activation, what are then the molecular links between the upstream events that link abnormal mitosis to the activation of the central executioner of apoptosis? It probably depends on the subtype of cell death. In the case of p53-dependent mitotic catastrophe, solid evidence is available that the transcription of some proapoptotic p53 target genes may determine the induction of MMP. Thus, Bax and Puma have been identified as the p53 target genes that induce apoptosis during the prophase when nonsynchronized cells are fused among each other (Roumier et al., 2003; Perfettini et al., 2004) . The inhibition of these proteins by antisense oligonucleotides or siRNA prevents the prophase-associated death induced by fusion of HeLa cells. The inhibition of p53, Puma or Bax thus stabilizes the DCm, prevents the release of Cyt. c and AIF from mitochondria and suppresses caspase-3 activation (Perfettini et al., 2004) . This indicates that caspase-3 activation occurs downstream of mitochondria, presumably as a result of Cyt. c release and the formation of the Cyt. c/Apaf-1/caspase-9 apoptosome complex. Conversely, chemical inhibition of caspases with Z-VAD.fmk does not affect the signs of MMP (Ferri et al., 2000a) , thus corroborating the notion that caspase activation is occurring downstream of MMP, in a model of syncytium-induced apoptosis.
In the case of metaphase-associated death, which is p53 independent, it appears that one particular caspase is activated upstream of mitochondria. In Chk2-inhibited syncytia, caspase-2 activation can be detected even when apoptosis is suppressed by overexpression Figure 4 Mitotic catastrophe demonstrates signs of apoptosis. HeLa cell syncytia generated in the presence of a chemical Chk2 inhibitor, debromohymenialdesine, undergo apoptosis during the metaphase of the cell cycle. During this stage, the manifest chromatin condensation (as determined by staining with Hoechst 33324) with microtubular dysorganization (as determined by immunostaining with an antitubulin antibody) (a), mitochondrial release of Cyt. c (b) and AIF (c), both detected with specific antibodies, caspase-3 activation, as determined with an antiserum that recognizes the proteolytically mature caspase-3, yet does not react with inactive procaspase-3 (d), as well as DNA fragmentation as detectable with the TUNEL method (e). In each case, a representative metaphase is shown before and after mitotic catastrophe has occurred Mitotic catastrophe M Castedo et al of vMIA (Castedo et al., 2004a) . Similarly, histone deacetylase inhibitors such as suberoylanilide hydroxamic acid, oxamflatin and depsipeptide can trigger the accumulation of cells with a 4N DNA content and subsequent apoptosis, and this process involves a primary caspase-2 activation that cannot be inhibited by Bcl-2 (Peart et al., 2003) . Importantly, in the model of Chk2-inhibited syncytia, caspase-2 depletion by RNAi prevents MMP. Both the depletion of caspase-2 and the direct inhibition of MMP (by vMIA) inhibit the proteolytic maturation of caspase-3 and subsequent mitotic death, indicating that the molecular order in this kind of metaphase-associated mitotic catastrophe is caspase-2-MMP-caspase-3 (Castedo et al., 2004a) . How caspase-2 is activated in this system remains a conundrum, however. It has been shown in the past that procaspase-2 can be activated in the nucleus as a result of DNA damage (Lassus et al., 2002; Paroni et al., 2002; Read et al., 2002; Robertson et al., 2002) . Moreover, it has been shown that caspase-2 can act on isolated mitochondria to trigger MMP, but the mitochondrial target protein of caspase-2 is yet to be identified (Guo et al., 2002) . Irrespective of these details, it appears however that, in the model of Chk2-inhibited syncytia, pancaspase inhibitors (which also act on caspase-2) can actually prevent MMP and mitotic cell death (Castedo et al., 2004a) , thereby preventing a cell death occurring during the metaphase and ultimately inducing the asymmetric division of polyploid cells in more than two daughter cells ( Figure 5 ).
Figure 5 Mitotic catastrophe and its suppression. HeLa cells stably transfected with a histone H2B-GFP construct (which allows for the monitoring of chromosome movement) were fused with PEG, followed by fluorescence videomicroscopy (a-c). Multipolar divisions of syncytia are filmed. In the presence of the Chk2/Chk1 inhibitor debromohymenialdesine only (a and b), syncytia progress from initial nuclear fusion (karyogamy) to a multipolar metaphase (a) and then to mitotic catastrophe (b). When the pancaspase inhibitor Z-VAD.fmk is added into the system, metaphases are followed by full karyokinesis and cytokinesis, resulting into asymmetric division (c The data discussed in this review suggest under which conditions mitotic catastrophe is induced. After failure to activate the G2/M checkpoint(s), cells with DNA lesions (or incomplete DNA replication) activate an apoptotic program that leads to the phenotypic manifestation of mitotic catastrophe, during the metaphase of the cell cycle. Suppression of the apoptotic program (and of the spindle checkpoint) then may lead to asymmetric cell division (Figure 5d ) or mitotic slippage, resulting into the generation of tetraploid cells which, when the polyploidy checkpoint is inactivated, can generate an aneuploid offspring ( Figure 6 ). It is tempting to speculate that these mechanisms could be important for cancer development. Most tumors develop in an (oligo)clonal and stochastic manner, through a multistep process. As a working hypothesis, it is tempting to assume that one of the mechanisms that contribute to oncogenesis may be what we might call a 'cytogenetic catastrophe'. Aneuploidization could result from the asymmetric division of polyploid cells, generated from an illicit cell fusion, as it may occur in vivo (DeWitt and Knight, 2002; Terada et al., 2002; Wurmser and Gage, 2002; Vassilopoulos et al., 2003) or from endoreplication/endomitosis (Nitta et al., 2003) . Indeed, polyploidy is frequently observed in neoplasia and constitutes a negative prognostic factor, while aneuploidy is a near-to-general characteristic of cancer (Slovak et al., 2000; Choma et al., 2001; Jallepalli and Lengaue, 2001; Shih et al., 2001; Lingle et al., 2002; Masuda and Takahashi, 2002a, b; Sen et al., 2002; Tort et al., 2003) . On theoretical grounds, polyploid cells (which possess more than two centrosomes) should divide in an asymmetric manner, thus generating aneuploid cells, containing an excess of chromosomes or lacking entire chromosomes (Brinkley, 2001; Nigg, 2001; D'Assoro et al., 2002; Lingle et al., 2002; Meraldi et al., 2002) . If chromosome segregation starts at a stage at which the replication of all chromosomes has not yet been completed (which normally is prevented by checkpoints) (Cahill et al., 1998) , problems of separation, possibly linked to DNA strand breaks and repair would lead, in addition, to partial deletions of chromosomes as well as to translocations (Gisselsson, 2003) . Most of the daughter cells generated as the result of a stochastic distribution of chromosomes should be doomed to death in the absence of genes coding for essential proteins. However, a small minority of abnormal cells could survive such a catastrophic event.
The scenario outlined above thus would develop in several successive steps: (i) the polyploidization resulting from illicit cellular fusion or endomitosis; (ii) the survival of such polyploid cells due to a suppression of the polyploidy checkpoint (which is executed at least in part by apoptosis); (iii) the asymmetric division of polyploid cells in daughter cells, perhaps resulting from the suppression of mitotic catastrophe; (iv) the Darwinian survival of the daughter cells. The resulting 'cytogenetic catastrophe' thus is a theoretical reconstruction of the stochastic and clonal nature of tumor cells that would develop in the context of simultaneous suppression of cell-cycle checkpoints and apoptosis. 
